Regentis Biomaterials RGNT
NYSE RGNT
$1.85 -0.06 (-3.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Regentis Biomaterials (RGNT) Other Non-Current Liabilities (2024)

Updated

Regentis Biomaterials (RGNT) posted Other Non-Current Liabilities of $160,000 for Q4 2024.

Analysis

Regentis Biomaterials (RGNT) Other Non-Current Liabilities (2024) Analysis & Trends

  • In prior years, Regentis Biomaterials' Other Non-Current Liabilities was $623,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Regentis Biomaterials 1.05 Mn -7.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 160,000.00
API Access

Regentis Biomaterials Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RGNT&period=max&api_key=YOUR_API_KEY